| The diarylquinoline TMC207 for multidrug-resistant tuberculosis AH Diacon, A Pym, M Grobusch, R Patientia, R Rustomjee, L Page-Shipp, ... New England Journal of Medicine 360 (23), 2397-2405, 2009 | 1094 | 2009 |
| Multidrug-resistant tuberculosis and culture conversion with bedaquiline AH Diacon, A Pym, MP Grobusch, JM de Los Rios, E Gotuzzo, I Vasilyeva, ... New England Journal of Medicine 371 (8), 723-732, 2014 | 913 | 2014 |
| Treatment of highly drug-resistant pulmonary tuberculosis F Conradie, AH Diacon, N Ngubane, P Howell, D Everitt, AM Crook, ... New England Journal of Medicine 382 (10), 893-902, 2020 | 885 | 2020 |
| 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial AH Diacon, R Dawson, F von Groote-Bidlingmaier, G Symons, A Venter, ... The Lancet 380 (9846), 986-993, 2012 | 574 | 2012 |
| Diagnostic tools in tuberculous pleurisy: a direct comparative study AH Diacon, BW Van de Wal, C Wyser, JP Smedema, J Bezuidenhout, ... European Respiratory Journal 22 (4), 589-591, 2003 | 552 | 2003 |
| Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ... New England Journal of Medicine 381 (25), 2429-2439, 2019 | 538 | 2019 |
| Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug … AH Diacon, PR Donald, A Pym, M Grobusch, RF Patientia, R Mahanyele, ... Antimicrobial agents and chemotherapy 56 (6), 3271-3276, 2012 | 507 | 2012 |
| Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ... New England Journal of Medicine 379 (17), 1621-1634, 2018 | 416 | 2018 |
| High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ... The Lancet infectious diseases 17 (1), 39-49, 2017 | 415 | 2017 |
| Bedaquiline in the treatment of multidrug-and extensively drug-resistant tuberculosis AS Pym, AH Diacon, SJ Tang, F Conradie, M Danilovits, C Chuchottaworn, ... European Respiratory Journal 47 (2), 564-574, 2016 | 413 | 2016 |
| Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis R Rustomjee, AH Diacon, J Allen, A Venter, C Reddy, RF Patientia, ... Antimicrobial agents and chemotherapy 52 (8), 2831-2835, 2008 | 394 | 2008 |
| Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound AH Diacon, MH Brutsche, M Soler Chest 123 (2), 436-441, 2003 | 391 | 2003 |
| A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis MJ Boeree, AH Diacon, R Dawson, K Narunsky, J Du Bois, A Venter, ... American journal of respiratory and critical care medicine 191 (9), 1058-1065, 2015 | 379 | 2015 |
| Why do we use 600 mg of rifampicin in tuberculosis treatment? J Van Ingen, RE Aarnoutse, PR Donald, AH Diacon, R Dawson, ... Clinical Infectious Diseases 52 (9), e194-e199, 2011 | 316 | 2011 |
| Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label … R Dawson, AH Diacon, D Everitt, C van Niekerk, PR Donald, DA Burger, ... The Lancet 385 (9979), 1738-1747, 2015 | 303 | 2015 |
| Tuberculous pleural effusions: advances and controversies MJ Vorster, BW Allwood, AH Diacon, CFN Koegelenberg Journal of thoracic disease 7 (6), 981, 2015 | 298 | 2015 |
| Intrapleural streptokinase for empyema and complicated parapneumonic effusions AH Diacon, J Theron, MM Schuurmans, BW Van de Wal, CT Bolliger American journal of respiratory and critical care medicine 170 (1), 49-53, 2004 | 279 | 2004 |
| Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients AH Diacon, R Dawson, M Hanekom, K Narunsky, A Venter, N Hittel, ... The International journal of tuberculosis and lung disease 15 (7), 949-954, 2011 | 269 | 2011 |
| Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study JM Bryant, SR Harris, J Parkhill, R Dawson, AH Diacon, P van Helden, ... The Lancet Respiratory Medicine 1 (10), 786-792, 2013 | 243 | 2013 |
| Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline AH Diacon, R Dawson, F von Groote-Bidlingmaier, G Symons, A Venter, ... American journal of respiratory and critical care medicine 191 (8), 943-953, 2015 | 239 | 2015 |